Malignant neoplastic disease
Information
- Disease name
- Malignant neoplastic disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04330664 | Active, not recruiting | Phase 1/Phase 2 | Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) | April 22, 2020 | December 24, 2024 |
| NCT05840510 | Active, not recruiting | Phase 1/Phase 2 | Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19) | August 7, 2023 | June 30, 2026 |
| NCT04975256 | Completed | Phase 1 | Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) | August 12, 2021 | November 15, 2022 |
| NCT03785249 | Recruiting | Phase 1/Phase 2 | Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 | December 26, 2018 | January 2026 |
| NCT05375994 | Recruiting | Phase 1/Phase 2 | Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients | August 1, 2022 | January 1, 2025 |